Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andrew M, Biedermann"'
Autor:
Neil C. Dalvie, Joseph R. Brady, Laura E. Crowell, Mary Kate Tracey, Andrew M. Biedermann, Kawaljit Kaur, John M. Hickey, D. Lee Kristensen, Alexandra D. Bonnyman, Sergio A. Rodriguez-Aponte, Charles A. Whittaker, Marina Bok, Celina Vega, Tarit K. Mukhopadhyay, Sangeeta B. Joshi, David B. Volkin, Viviana Parreño, Kerry R. Love, J. Christopher Love
Publikováno v:
Microbial Cell Factories, Vol 20, Iss 1, Pp 1-14 (2021)
Abstract Background Vaccines comprising recombinant subunit proteins are well-suited to low-cost and high-volume production for global use. The design of manufacturing processes to produce subunit vaccines depends, however, on the inherent biophysica
Externí odkaz:
https://doaj.org/article/41653df3a0e545ec8a33dc49cc46216b
Publikováno v:
ACS Synthetic Biology
Genetic engineering of industrial cell lines often requires knockout of multiple endogenous genes. Tools like CRISPR-Cas9 have enabled serial or parallelized gene disruption in a wide range of industrial organisms, but common practices for the screen
Autor:
Kerry R. Love, Andrew M. Biedermann, Isabella R. Gengaro, J. Christopher Love, Sergio A. Rodriguez-Aponte
Publikováno v:
Biotechnology and Bioengineering. 119:59-71
Developing media to sustain cell growth and production is an essential and ongoing activity in bioprocess development. Modifications to media can often address host or product-specific challenges, such as low productivity or poor product quality. For
Autor:
Moo Sun Hong, Andrew J. Maloney, Tarit Mukhopadhyay, J. Christopher Love, Andrew M. Biedermann, Richard D. Braatz, M. Lourdes Velez-Suberbie, Kerry R. Love
Publikováno v:
Biotechnology and Bioengineering. 118:1199-1212
The methylotrophic yeast Pichia pastoris is widely used as a microbial host for recombinant protein production. Bioreactor models for P. pastoris can inform understanding of cellular metabolism and can be used to optimize bioreactor operation. This a
Autor:
J. Christopher Love, Laura E. Crowell, Umesh Shaligram, Neil C. Dalvie, Rakesh R Lothe, Christopher A Naranjo, Seraphin Castelino, Ryan S Johnston, Charles A. Whittaker, Meghraj P Rajurkar, Harish D Rao, Mary Kate Tracey, Andrew M. Biedermann, Sergio A. Rodriguez-Aponte
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Prevention of COVID-19 on a global scale will require the continued development of high-volume, low-cost platforms for the manufacturing of vaccines to supply ongoing demand. Vaccine candidates based on recombinant protein subunits remain important b
Autor:
Charles A. Whittaker, Aiquan Chang, J. Christopher Love, Hanne Leth Andersen, Lisa H. Tostanoski, Ozan S. Kumru, Nicolas Collin, Brooke Fiala, Megan Lok, Neil P. King, Brittany L. Hartwell, Danielle L Camp, Joseph R. Brady, Mary Kate Tracey, Andrew M. Biedermann, Kristen A Rodrigues, Harry Kleanthous, Jing Yang Wang, Katherine McMahan, Judith M. Silverman, Murillo Silva, Sergio A. Rodriguez-Aponte, David B. Volkin, Darrell J. Irvine, Thomas Courant, Maciel Porto, Sangeeta B. Joshi, Jingyou Yu, Patrice M. Dubois, Swagata Kar, Dan H. Barouch, Ashley A. Lemnios, Lauren Carter, Christopher A Naranjo, Ryan S Johnston, Celia Lebas, Dongsoo Yun, Neil C. Dalvie, Carl Walkey, Natalie Brunette, Laura E. Crowell, Kerry R. Love, Kawaljit Kaur, Mark G. Lewis
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Global containment of COVID-19 still requires accessible and affordable vaccines for low- and middle-income countries (LMICs).1 Recently approved vaccines provide needed interventions, albeit at prices that may limit their global access.2 Subunit vac
Autor:
Neil C, Dalvie, Andrew M, Biedermann, Sergio A, Rodriguez-Aponte, Christopher A, Naranjo, Harish D, Rao, Meghraj P, Rajurkar, Rakesh R, Lothe, Umesh S, Shaligram, Ryan S, Johnston, Laura E, Crowell, Seraphin, Castelino, Mary Kate, Tracey, Charles A, Whittaker, J Christopher, Love
Publikováno v:
Biotechnology and Bioengineering
Prevention of COVID‐19 on a global scale will require the continued development of high‐volume, low‐cost platforms for the manufacturing of vaccines to supply ongoing demand. Vaccine candidates based on recombinant protein subunits remain impor
Autor:
Kristen A Rodrigues, Mary Kate Tracey, Andrew M. Biedermann, Harry Kleanthous, Darrell J. Irvine, Judith M. Silverman, Danielle L Camp, Kerry R. Love, Lauren Carter, Thomas Courant, Neil C. Dalvie, Lisa H. Tostanoski, Megan Lok, J. Christopher Love, Nicolas Collin, Katherine McMahan, Swagata Kar, Hanne Leth Andersen, Ashley A. Lemnios, Charles A. Whittaker, Laura E. Crowell, Celia Lebas, Ozan S. Kumru, Joseph R. Brady, Brittany L. Hartwell, Sergio A. Rodriguez-Aponte, Kawaljit Kaur, David B. Volkin, Murillo Silva, Maciel Porto, Patrice M. Dubois, Dan H. Barouch, Neil P. King, Mark G. Lewis, Aiquan Chang, Sangeeta B. Joshi, Jingyou Yu, Christopher A Naranjo, Ryan S Johnston, Dongsoo Yun
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance Most of the global population resides in low- and middle-income countries, where current vaccines for COVID-19 remain largely unavailable. For the COVID-19 pandemic, the world will need access to >10 billion doses of vaccines, or more th